Humans102,330 patientsCohort study

Exploring the Relationship Between Dolutegravir and Diabetes Using Routine Data of Patients on Anti-Retroviral Treatment in a High HIV Prevalence Setting

Figure 1. Flowchart of the study population
Open the figure at full size
Figure 1. Flowchart of the study populationFlowchart of the study populationHaumba et al. · CC BY

Medical Research Archives

Abstract

Background Dolutegravir has been associated with excessive weight gain and type 2 diabetes mellitus (T2DM) The study aimed to describe the incidence and prevalence of type 2 diabetes mellitus in a cohort of patients exposed and non-exposed to dolutegravir containing antiretroviral therapy in Eswatini.

The paper

Georgetown University · Georgetown University Medical Center

Medical Research Archives · 1 Feb 2026 · CC BY

doi.org/10.18103/mra.v14i2.7309PubMed 42787810

More on Type 2 diabetes